| 1 | [SID103513903] | Active | | | Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in nicked form 2 at 2.5 uM by agarose gel electrophoresis in presence of Cu2+ [AID377525, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Active | | BioAssay | Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in nicked form 2 at 2.5 uM by agarose gel electrophoresis in presence of Cu2+ | | AID | 377525 | | BioAssay type | Literature | | Target | | | PubMed | 11000034 | | Data Table |  |
|
| 2 | [SID103513903] | Active | | | Antidiabetic activity in STZ-induced diabetic Wistar rats assessed as increase in response to exogenous insulin at 7.2 mg/kg, iv tid for 3 days [AID685327, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Active | | BioAssay | Antidiabetic activity in STZ-induced diabetic Wistar rats assessed as increase in response to exogenous insulin at 7.2 mg/kg, iv tid for 3 days | | AID | 685327 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 3 | [SID103513903] | Active | | | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered 30 mins prior to glucose challenge measured after 5 mins [AID685328, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Active | | BioAssay | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered 30 mins prior to glucose challenge measured after 5 mins | | AID | 685328 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 4 | [SID103513903] | Active | | | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered 30 mins prior to glucose challenge measured after 30 mins [AID685329, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Active | | BioAssay | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered 30 mins prior to glucose challenge measured after 30 mins | | AID | 685329 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 5 | [SID103513903] | Unspecified | IC50 | 100 | Antiinflammatory activity in human neutrophils assessed as fMLP-induced superoxide release after 5 mins by spectrometry [AID311335, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Antiinflammatory activity in human neutrophils assessed as fMLP-induced superoxide release after 5 mins by spectrometry | | AID | 311335 | | BioAssay type | Literature | | Target | | | PubMed | 17822293 | | Data Table |  |
|
| 6 | [SID103513903] | Unspecified | IC50 | 100 | Antioxidant activity assessed as DPPH free radical scavenging activity within 10 mins [AID445109, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Antioxidant activity assessed as DPPH free radical scavenging activity within 10 mins | | AID | 445109 | | BioAssay type | Literature | | Target | | | PubMed | 19822425 | | Data Table |  |
|
| 7 | [SID103513903] | Unspecified | MIC | 137.26 | Antitubercular activity against Mycobacterium tuberculosis 90-221387 [AID403754, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | MIC | 137.26 [uM] | | BioAssay | Antitubercular activity against Mycobacterium tuberculosis 90-221387 | | AID | 403754 | | BioAssay type | Literature | | Target | | | PubMed | 16180806 | | Data Table |  |
|
| 8 | [SID103513903] | Unspecified | IC50 | 300 | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs [AID436320, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | IC50 | 300 [uM] | | BioAssay | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs | | AID | 436320 | | BioAssay type | Literature | | Target | | | PubMed | 18986199 | | Data Table |  |
|
| 9 | [SID103513903] | Unspecified | MIC | 400 | Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by agar dilution method [AID405575, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | MIC | 400 [uM] | | BioAssay | Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by agar dilution method | | AID | 405575 | | BioAssay type | Literature | | Target | | | PubMed | 18471021 | | Data Table |  |
|
| 10 | [SID103513903] | Unspecified | | | Induction of pSP64 plasmid DNA relaxation by agarose gel electrophoresis in presence of Cu2+ [AID377522, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Induction of pSP64 plasmid DNA relaxation by agarose gel electrophoresis in presence of Cu2+ | | AID | 377522 | | BioAssay type | Literature | | Target | | | PubMed | 11000034 | | Data Table |  |
|
| 11 | [SID103513903] | Unspecified | | | Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in nicked form 2 at 10 uM by agarose gel electrophoresis [AID377523, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in nicked form 2 at 10 uM by agarose gel electrophoresis | | AID | 377523 | | BioAssay type | Literature | | Target | | | PubMed | 11000034 | | Data Table |  |
|
| 12 | [SID103513903] | Unspecified | | | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 32 nmol relative to TPA [AID377570, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 32 nmol relative to TPA | | AID | 377570 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 13 | [SID103513903] | Unspecified | | | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 16 nmol relative to TPA [AID377571, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 16 nmol relative to TPA | | AID | 377571 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 14 | [SID103513903] | Unspecified | | | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 3.2 nmol relative to TPA [AID377572, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 3.2 nmol relative to TPA | | AID | 377572 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 15 | [SID103513903] | Unspecified | | | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 0.32 mol relative to TPA [AID377573, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells assessed as EA activation at 0.32 mol relative to TPA | | AID | 377573 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 16 | [SID103513903] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 32 nmol by trypan blue assay [AID377574, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 32 nmol by trypan blue assay | | AID | 377574 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 17 | [SID103513903] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 16 nmol by trypan blue assay [AID377575, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 16 nmol by trypan blue assay | | AID | 377575 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 18 | [SID103513903] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 3.2 nmol by trypan blue assay [AID377576, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 3.2 nmol by trypan blue assay | | AID | 377576 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 19 | [SID103513903] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 0.32 nmol by trypan blue assay [AID377577, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 0.32 nmol by trypan blue assay | | AID | 377577 | | BioAssay type | Literature | | Target | | | PubMed | 11076549 | | Data Table |  |
|
| 20 | [SID103513903] | Unspecified | | | Antioxidant activity against linoleic acid assessed as inhibition of beta-carotene bleaching at 12 uM after 180 mins [AID445112, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Antioxidant activity against linoleic acid assessed as inhibition of beta-carotene bleaching at 12 uM after 180 mins | | AID | 445112 | | BioAssay type | Literature | | Target | | | PubMed | 19822425 | | Data Table |  |
|
| 21 | [SID103513903] | Unspecified | IC50 | | Cytotoxicity against mouse L1210 cells [AID282835, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Cytotoxicity against mouse L1210 cells | | AID | 282835 | | BioAssay type | Literature | | Target | | | PubMed | 16279782 | | Data Table |  |
|
| 22 | [SID103513903] | Unspecified | | | Activity against caspase-mediated apoptosis in mouse L1210 cells [AID282834, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Activity against caspase-mediated apoptosis in mouse L1210 cells | | AID | 282834 | | BioAssay type | Literature | | Target | | | PubMed | 16279782 | | Data Table |  |
|
| 23 | [SID103513903] | Unspecified | | | Antihyperglycemic activity in STZ-induced diabetic Wistar rats assessed as reduction in plasma glucose levels at 1.8 mg/kg, iv administered as bolus dose measured after 60 mins [AID685323, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Antihyperglycemic activity in STZ-induced diabetic Wistar rats assessed as reduction in plasma glucose levels at 1.8 mg/kg, iv administered as bolus dose measured after 60 mins | | AID | 685323 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 24 | [SID103513903] | Unspecified | | | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered as bolus dose measured after 60 mins [AID685325, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered as bolus dose measured after 60 mins | | AID | 685325 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 25 | [SID103513903] | Unspecified | | | Induction of glucose uptake in rat L6 cells after 60 mins by 2-NBDG fluorescence assay [AID685326, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Induction of glucose uptake in rat L6 cells after 60 mins by 2-NBDG fluorescence assay | | AID | 685326 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 26 | [SID103513903] | Unspecified | | | Antihyperglycemic activity in STZ-induced diabetic Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered as bolus dose measured after 60 mins [AID685322, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Antihyperglycemic activity in STZ-induced diabetic Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered as bolus dose measured after 60 mins | | AID | 685322 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 27 | [SID103513903] | Unspecified | | | Antihyperglycemic activity in iv dosed STZ-induced diabetic Wistar rats assessed as reduction in plasma glucose levels administered as bolus dose measured after 60 mins [AID685321, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Unspecified | | BioAssay | Antihyperglycemic activity in iv dosed STZ-induced diabetic Wistar rats assessed as reduction in plasma glucose levels administered as bolus dose measured after 60 mins | | AID | 685321 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 28 | [SID103513903] | Inactive | | | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered 30 mins prior to glucose challenge measured after 120 mins [AID685320, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Inactive | | BioAssay | Antihyperglycemic activity in Wistar rats assessed as reduction in plasma glucose levels at 7.2 mg/kg, iv administered 30 mins prior to glucose challenge measured after 120 mins | | AID | 685320 | | BioAssay type | Literature | | Target | | | PubMed | 22880723 | | Data Table |  |
|
| 29 | [SID103513903] | Inactive | | | Prooxidant effect on Cu2+-induced pBR322 DNA damage at 0.35 to 45 uM after 1 hr [AID445117, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Inactive | | BioAssay | Prooxidant effect on Cu2+-induced pBR322 DNA damage at 0.35 to 45 uM after 1 hr | | AID | 445117 | | BioAssay type | Literature | | Target | | | PubMed | 19822425 | | Data Table |  |
|
| 30 | [SID103513903] | Inactive | | | Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in linear duplex form 3 by agarose gel electrophoresis [AID377529, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Inactive | | BioAssay | Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in linear duplex form 3 by agarose gel electrophoresis | | AID | 377529 | | BioAssay type | Literature | | Target | | | PubMed | 11000034 | | Data Table |  |
|
| 31 | [SID103513903] | Inactive | | | Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation in human plasma LDL after 18 hrs by gel electrophoresis [AID445110, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103513903 | | CID | 8655 | | Outcome | Inactive | | BioAssay | Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation in human plasma LDL after 18 hrs by gel electrophoresis | | AID | 445110 | | BioAssay type | Literature | | Target | | | PubMed | 19822425 | | Data Table |  |
|